52 completed. 52 Phase 2, 13 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 52 | Completed 52 |
| Phase 1 | 13 | Completed 13 |
| Phase 3 | 3 | Completed 3 |
Follow Peritoneal Diseases: new trials by email Literature Review of Peritoneal Diseases trials Research Report on Peritoneal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy oral iohexol, Lymphangiography and Embolization - Chylous Ascites, Abdominal Neoplasm | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 42 | 2025-02-15 | 2026-03-06 |
| Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery | Phase 1 / Phase 2 | Completed | Ziauddin University | 60 | 2025-01-06 | 2026-09-02 |
| Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis Paclitaxel, Nilotinib, ECG - Gynecologic Cancer, Gynecologic Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 21 | 2022-10-13 | 2026-06-25 |
| A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets pegsitacianine - Peritoneal Carcinomatosis | Phase 2 | Completed | OncoNano Medicine, Inc. | 51 | 2021-11-30 | 2024-11-08 |
| Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2 / Phase 3 | Completed | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 12 | 2021-08-31 | 2025-08-11 |
| Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies LUM Imaging System - Peritoneal Metastases | Phase 1 / Phase 2 | Completed | Lumicell, Inc. | 18 | 2019-03-18 | 2026-01-16 |
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 Paclitaxel, mFOLFOX6 regimen - Gastric Cancer Stage IV, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Completed | Seoul National University Bundang Hospital | 35 | 2018-12-24 | 2023-12-05 |
| PIPAC for Peritoneal Metastases of Colorectal Cancer repetitive ePIPAC-OX - Colorectal Neoplasms, Peritoneal Neoplasms | Phase 2 | Completed | Koen Rovers | 20 | 2017-10-01 | 2019-10-15 |
| The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis Cholecalciferol (2000iu qd), Routine therapy for PD - Peritoneal Dialysis-associated Peritonitis, Vitamin D Deficiency | Phase 2 | Completed | Peking University First Hospital | 60 | 2017-09-30 | 2021-08-18 |
| Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC - Peritoneum; Carcinomatosis, Peritoneal Neoplasms | Phase 2 | Completed | Michael Bau Mortensen | 143 | 2016-12-01 | 2022-10-07 |
| Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer Cisplatin, Hyperthermic Intraperitoneal Chemotherapy, Mitomycin - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 24 | 2016-09-01 | 2024-09-19 |
| Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer Olvi-Vec, Platinum-doublet with or without bevacizumab - Ovarian Cancer, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Completed | Genelux Corporation | 46 | 2016-05-01 | 2026-06-12 |
| Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer Cytoreductive surgery, IPEC with Cisplatin (75mg/m²), IPEC with Cisplatin (100mg/m²) - Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Completed | University Hospital, Ghent | 56 | 2016-03-01 | 2023-11-27 |
| Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis perioperative chemotherapy plus bevacizumab, cytoreductive surgery, Intraperitoneal Oxaliplatin - Colorectal Neoplasms | Phase 2 | Completed | University Hospital, Ghent | 60 | 2015-11-04 | 2024-01-30 |
| Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors Pressurized IntraPeritoneal Air-flow Chemotherapy (PIPAC) fixed repeated dose, Pressurized IntraPeritoneal Air-flow Chemotherapy (PIPAC) increasing single dose - Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Completed | Fondazione del Piemonte per l'Oncologia | 105 | 2015-10-01 | 2020-09-17 |
| Treating Peritoneal Carcinomatosis With PIPAC PIPAC - Peritoneal Carcinomatosis | Phase 2 | Completed | Michael Bau Mortensen | 35 | 2015-03-01 | 2017-09-12 |
| Comparative Evaluation of Intra-operative Peritoneal Lavage With Super Oxidized Solution and Normal Saline in Peritonitis Cases Super Oxidized Solution in group I - Peritonitis | Phase 2 | Completed | Maharishi Markendeswar University (Deemed to be University) | 290 | 2014-12-01 | 2016-08-30 |
| Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial MOC31PE Immunotoxin - Colorectal Neoplasms | Phase 1 / Phase 2 | Completed | Oslo University Hospital | 15 | 2014-08-01 | 2017-05-30 |
| αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies DC vaccine, Celecoxib, Interferon Alfa-2b - Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma | Phase 1 / Phase 2 | Completed | David Bartlett | 64 | 2014-07-01 | 2020-07-20 |
| Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT Modulated Electro-Hyperthermia (mEHT), TCM Herbal Decoction (Shi Pi), IPCI (CDDP+5FU) - Peritoneal Neoplasms, Ascites | Phase 2 | Completed | Galenic Research Institute Ltd | 260 | 2014-01-01 | 2017-05-19 |
Showing 20 of 52. Sign in to see all of them.
Peritoneal Neoplasms (42) · Ovarian Neoplasms (21) · Fallopian Tube Neoplasms (15) · Colorectal Neoplasms (6) · Neoplasms (6) · Peritonitis (6) · Carcinoma (4) · Appendiceal Neoplasms (3) · Ascites (3) · Neoplasms, Glandular and Epithelial (3) · Stomach Neoplasms (3) · Abdominal Neoplasms (2) · Adenocarcinoma (2) · Carcinoma, Ovarian Epithelial (2) · Chylous Ascites (2)
Digestive System Diseases (52) · Neoplasms by Site (43) · Digestive System Neoplasms (42) · Abdominal Neoplasms (41) · Neoplasms (38) · Endocrine Gland Neoplasms (22) · Female Urogenital Diseases (22) · Female Urogenital Diseases and Pregnancy Complications (22) · Urogenital Diseases (22) · Adnexal Diseases (21) · Endocrine System Diseases (21) · Genital Diseases (21) · Gonadal Disorders (21) · Genital Diseases, Female (20)
Paclitaxel (10) · Cisplatin (7) · Carboplatin (5) · Cytoreduction Surgical Procedures (5) · Hyperthermic Intraperitoneal Chemotherapy (4) · Oxaliplatin (4) · Bevacizumab (3) · Doxorubicin (3) · Fluorouracil (3) · catumaxomab (3) · Acetylcysteine (2) · Docetaxel (2) · Mitomycin (2) · Octreotide (2) · 1,2-diaminocyclohexaneplatinum II citrate (1)
National Cancer Institute (NCI) (3) · University Hospital, Ghent (3) · AGO Study Group (2) · Eli Lilly and Company (2) · Jules Bordet Institute (2) · M.D. Anderson Cancer Center (2) · Michael Bau Mortensen (2) · Novartis Pharmaceuticals (2) · TC Erciyes University (2) · AIO-Studien-gGmbH (1) · ARCAGY/ GINECO GROUP (1) · Albert Einstein College of Medicine (1) · Belgian Gynaecological Oncology Group (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Critical Biologics Corporation (1)
United States (19) · Belgium (7) · Germany (6) · China (3) · France (3) · Canada (2) · Denmark (2) · Netherlands (2) · Spain (2) · Turkey (Türkiye) (2) · Austria (1) · Hong Kong (1) · Italy (1) · Japan (1) · Norway (1)
Gabriel Liberale, MD (2) · Wim P Ceelen, MD, PhD (2) · Agustin Garcia, MD (1) · Andrew M Blakely, M.D. (1) · Brian D Badgwell (1) · Bulent Tokgoz, MD (1) · Cary Presant, MD (1) · Charles Levenback, MD (1) · Clifford LK Pang, PhD (1) · David L Bartlett, MD (1) · Djamila Boerma, MD, PhD (1)
PMID 11762804, PMID 14745444, PMID 16452199, PMID 16790085, PMID 17513629, PMID 19181369, PMID 19617379, PMID 19942597, PMID 20008305, PMID 21424369, PMID 21551083, PMID 21733566, PMID 22096279, PMID 23377563, PMID 23474348, PMID 23765417, PMID 23904932, PMID 24006094, PMID 24275155, PMID 24447964, PMID 24756812, PMID 25073872, PMID 25254563, PMID 25885838, PMID 26673788, PMID 28529748, PMID 29773661, PMID 29899763, PMID 30463745, PMID 30755498, PMID 30911656, PMID 30911669, PMID 31303716, PMID 31352425, PMID 31779675, PMID 31862004, PMID 32556731, PMID 32572849, PMID 33037105, PMID 33544279, PMID 34070561, PMID 34757489, PMID 37227734, PMID 37993560, PMID 42383154, PMID 8862729
2017 (1), P01CA132714 (1)